SUBSCRIBE: eNewsletter
A new analysis of results from the SPRINT trial finds that across age groups, intensive blood pressure control may lengthen a person’s remaining lifespan by 4% to 9%.
A novel report on US opioid misuse melds results from a Harris Poll of 500 primary care physicians with Quest Diagnostics data on 4.4 million drug monitoring tests.
We preview findings of 2 studies on negative CV effects of e-cigarettes--on metabolic profiles and coronary blood flow--to be presented at the AHA 2019 Scientific Sessions next week.
The American College of Physicians today issued a guidance statement for routine colorectal cancer screening for average-risk adults.
The worst state for drug sales on school grounds? The best state for detox and rehab facilities? Test your best guess with these and 6 more best/worst comparisons.
Screening for depression among ACS patients is widely recommended by professional guidelines, but a new study suggests little return on the investment.
The SGLT2 inhibitor, on October 21, 2019 was granted a label expansion from FDA for the prevention of hospitalization for heart failure in patients with T2D.
Lasmitidan is the first 5-HT1F receptor agonist to receive FDA approval and was found superior to placebo for reduction of migraine pain and most bothersome symptom at 2 hours.
Motivational interviewing uses the common human problem of ambivalence about change to help clients shape their own solutions.
For people with type 2 diabetes, receiving motivational messages via mobile text was associated with reduced A1c vs patients who received usual care.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
